MEGGLE AG appoints three new directors to Management Board

Wasserburg, Germany: – MEGGLE have appointed three new directors to their Management board. From 1st of March 2018, Marcus Hormuth (47) and Matthias Oettel (52) and from 1st of April 2018 Dr. Stefan Schmale (55), three more experts join the Board of the dairy factory in Wasserburg. Together with CEO Reinhold Schlensok they will lead the family company into the future. All three have been recruited from outside the company.

MEGGLE have also appointed Prof. Bruno Meiser, MD, currently Head of the Transplantation Centre Munich of the LMU, to its Supervisory Board, joining Toni Meggle (Chairman), Prof. Dr. Claus Hipp (deputy Chairman) and Marina Meggle.

Generation change

Toni Meggle, owner and Chairman of the Supervisory Board at MEGGLE, commented: “As planned, this is the next step for a successful future of MEGGLE. The generation change, which started with the appointment of Reinhold Schlensok, has now been completed.”

CEO Reinhold Schlensok added: “I’m pleased that with Marcus Hormuth, Matthias Oettel and Dr. Stefan Schmale we have been able to bring three highly experienced managers onto the MEGGLE Board.”

“With this new and experienced team, we will continue to lead MEGGLE successfully into the future,” said Mr. Schlensok.

Marcus Hormuth

Marcus Hormuth, 47, is returning to MEGGLE as Director of the Functional Products business division after more than four years away, as Director for International Sales at Street One GmbH. Previously, he worked for the MEGGLE dairy company between 2000 and 2013, beginning his career as Sales Manager in Wasserburg before establishing the MEGGLE sites in Singapore and White Plains, USA.

Matthias Oettel

Until most recently Matthias Oettel worked as Director Sales & Marketing at Zott SE & Co. KG and was responsible for D-A-CH-Region, Northern, Western and Southern Europe. Before joining Zott, Mr. Oettel, 52, acted in key positions for Bel Deutschland GmbH, Nöm International AG in Austria and Danone GmbH. As member of the MEGGLE Board, he will now be responsible for Consumer Products.

Dr. Stefan Schmale

Dr. Stefan Schmale, 55, spent more than eight years as commercial Managing Director at Paulaner Brauerei GmbH & Co. KG in Munich. His previous experience includes various financial management positions at VIAG AG Group, Creatogen AG and Schaeffler KG. As Chief Financial Officers (CFO) of MEGGLE AG, he will be responsible for Controlling, Finance and IT.

About MEGGLE Wasserburg

Bavarian-based MEGGLE Wasserburg is one of the world’s experts in lactose based excipients and powder technology.

From its roots as a dairy operation in the late 1880s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.

MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage form applications, where they can deliver maximum performance.

The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for modified sustained release and controlled release formulations.